GM1 Gangliosidosis is a rare genetic disorder that affects the nervous system. It is caused by a deficiency of an enzyme called beta-galactosidase, which leads to the accumulation of a substance called GM1 ganglioside in the body's cells. The ICD10 code for GM1 Gangliosidosis is E75.0. Unfortunately, there is no specific ICD9 code for this condition as it has been replaced by the ICD10 coding system.
GM1 Gangliosidosis is a rare genetic disorder characterized by the deficiency of an enzyme called beta-galactosidase, which leads to the accumulation of a specific type of fat called GM1 ganglioside in cells. The ICD-10 code for GM1 Gangliosidosis is E75.01. This code falls under the category of "other sphingolipidosis" in the ICD-10 coding system.
In contrast, the ICD-9 code for GM1 Gangliosidosis is 330.1. It is classified under the broader category of "other specified degenerative diseases of the nervous system." However, it is important to note that the ICD-9 system has been replaced by the ICD-10 system, which provides a more detailed and comprehensive coding structure for accurate diagnosis and billing purposes.
GM1 Gangliosidosis is a progressive disorder that affects various organ systems, including the nervous system. Symptoms may include developmental delay, muscle weakness, seizures, impaired vision, and intellectual disability. The condition is typically diagnosed through clinical evaluation, genetic testing, and enzyme activity assays. Treatment options are limited, and management primarily focuses on supportive care to alleviate symptoms and improve quality of life for affected individuals.